Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G.

Thus, we propose this inhibitor as a lead molecule to guide subsequent efforts to develop clinically relevant potent and selective CatG inhibitors for use as anti-inflammatory agents.